At the invite-only California Peptide Club in a San Francisco mansion, 'not for human consumption' is part of the draw.

New INTIMET study finds metformin helps people with type 1 diabetes reduce insulin needs by 12 per cent without affecting ...

UCSF research led to the world’s first immunotherapy to prevent type 1 diabetes. Now, scientists are aiming for the ‘holy ...

Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data ...

“Fasting insulin is one of the most crucial — and most overlooked — biomarkers in medicine because it reveals how hard your ...

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

A new gene therapy could replace daily insulin injections for type 1 diabetes patients — and human trials are set to begin ...

Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...

Add Yahoo as a preferred source to see more of our stories on Google. MIT researchers are developing an implantable device that contains insulin-producing cells. (CREDIT: MIT Researchers) A small ...

Data from the ONWARDS clinical trial program supported the efficacy of once-weekly insulin icodec-abae compared with daily basal insulin. The Food and Drug Administration (FDA) has approved Awiqli ® ...

What Is Awiqli, and Why Does It Matter? Awiqli (insulin icodec-abae) is a once-weekly long-acting basal insulin injection approved by the FDA for adults with type 2 diabetes. It helps lower blood ...